Tenon Medical Inc (TNON) Financials

$4.08

$-0.12 (-2.86%)

As on 18-Sep-2026 16:28EDT

Market cap

$3 Mln

Revenue (TTM)

$5 Mln

P/E Ratio

--

P/B Ratio

4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	5.33	3.94	3.28	2.93	0.69	0.16
Cost of Revenue	1.80	1.59	1.57	1.69	1.33	0.06
Gross Profit	3.53	2.36	1.71	1.24	-0.64	0.11
Operating Expenses	16.46	15.15	15.48	16.97	18.08	6.57
Operating Profit (EBIT)	-12.93	-12.79	-13.77	-15.73	-18.73	-6.46
Other Income	--	--	--	--	--	--
Profit before Tax	-13.67	-12.56	-13.67	-15.58	-18.92	-7.08
Provision for Tax	--	--	-13.67	--	0.19	0.59
Profit after Tax (Net Income)	-13.67	-12.56	-13.67	-15.58	-18.92	-7.05
Minority Interest	--	--	--	--	0.00	0.03
Consolidated Profit	--	--	--	--	-18.92	-7.05

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-1.74	5.04	5.97	0.78	6.25	-20.55
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	3.36	2.51	2.00	2.43	2.31	14.55
Current Liabilities	8.31	3.21	1.87	3.14	2.53	15.27
Total Liabilities	18.23	10.76	9.84	6.35	11.09	9.27

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	5.12	3.99	1.63	2.46	1.74	1.60
Current Assets	4.81	6.77	8.21	3.89	9.35	7.67
Total Assets	18.23	10.76	9.84	6.35	11.09	9.27
Total Debt*	5.68	0.14	0.43	1.86	0.91	14.62
Net Current Assets	-3.50	3.56	6.34	0.75	6.82	-7.60

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-10.75	-9.88	-12.18	-12.03	-4.29
Cash Flow from Investing Activities	--	-1.02	-0.19	6.14	-2.88	-4.50
Cash from Financing Activities	--	8.99	14.13	6.30	14.11	11.47
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-46.34	-40.49	-394.03	-1,712.20	-4,729.25	-17,620.00
Cash EPS ($)	-42.75	-38.78	-375.16	-1,673.30	-4,657.00	-17,335.05
Adjusted Book Value ($)	-14.57	16.25	172.07	85.49	1,563.00	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-34.65	-284.67	-1,338.79	-3,006.25	-10,730.00
Free Cash Flow per Share ($)	--	-35.53	-290.03	-1,378.46	-3,218.00	-10,985.00

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-216.86	-302.70	-318.04	-3,075.93	165.80
ROE (%)	--	-228.06	-405.19	-443.27	264.57	59.49
ROA (%)	-85.66	-121.89	-168.93	-178.74	-185.82	-145.88
EBIT Margin (%)	-177.06	-318.36	-416.20	-531.42	-2,686.40	-4,037.50
Net Margin (%)	-256.33	-318.36	-417.24	-532.14	-2,737.63	-4,405.00
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	80.90	0.20	0.12	3.24	3.32	2.65
EBIT Growth (%)	25.42	7.94	12.35	16.18	-187.35	-501.60
Net Profit Growth (%)	-7.97	8.17	12.25	17.63	-168.40	-1,104.42
EPS Growth (%)	82.43	0.90	0.77	0.64	0.73	-8.03
Book Value Growth (%)	-117.17	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.02	0.00	0.00	0.00	--
Price / Book Value	4.02	0.06	0.01	0.02	0.00	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.13	0.28	0.47	0.04	0.42	--
Close Price ($)	11.42	33.30	65.80	442.40	4,424.00	--
High Price ($)	86.80	204.75	552.59	7,672.00	167,692.00	--
Low Price ($)	10.15	29.75	58.43	215.60	3,192.00	--
Market Cap ($ Cr)	2.72	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.03	0.07	2.39	0.15	-0.71
Short term debt to equity ratio	-2.61	0.03	0.05	1.84	0.04	-0.67
Current Ratio	0.58	2.11	4.39	1.24	3.69	0.50
Quick Ratio	0.48	1.78	4.07	1.06	3.53	0.49
Interest Coverage	-12.29	--	-401.15	-740.95	-52.44	-10.40

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	36.52	43.05	26.34	17.96	34.88	47.50
Asset Turnover	0.33	0.38	0.40	0.34	0.07	0.03
Receivable days	--	118.59	77.41	47.84	83.78	103.27
Inventory Days	--	191.15	135.28	104.90	82.67	767.98
Payable days	--	139.79	93.53	106.41	140.94	3,543.56
Cash Conversion Cycle	--	169.94	119.16	46.32	25.51	-2,672.31

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.